- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Insights 3548 results
Client Alert
Mai 14, 2025
AI Quarterly Update: Recent AI Legislation Efforts Signal Potential Challenges for State-Led Regulatory Approach
Client Alert
Mai 14, 2025
What is new in: Private Credit Secondaries
Client Alert
Mai 9, 2025
New Executive Order Promotes Domestic Production of Critical Medicines
Client Alert
Client Alert
Newsletter
Mai 5, 2025
Health Headlines – May 5, 2025
Client Alert
Mai 5, 2025
Cunningham v. Cornell University: ERISA Claims Are Now Much More Costly and Difficult to Defend
Article
Mai 1, 2025
FDA Releases Draft Guidance on Submission Recommendations for AI-Enabled Device Software Functions
Newsletter
April 30, 2025
All Wrapped Up: Extended Producer Responsibility for Packaging, March 2025
Article
April 30, 2025
Private credit secondaries see continued growth
Client Alert
April 30, 2025
What is ‘Gender’ Under the Equality Act? Landmark Ruling – but Controversy Continues
Newsletter
April 30, 2025
Data, Privacy & Security Practice Report – April 2025